BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+15.25%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$133M
AUM Growth
+$133M
Cap. Flow
+$4.07M
Cap. Flow %
3.05%
Top 10 Hldgs %
72.54%
Holding
56
New
1
Increased
8
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$96B
$46.6M 34.92% 728,585
PRTA icon
2
Prothena Corp
PRTA
$441M
$10.7M 7.99% 156,111 +27,716 +22% +$1.89M
NBIX icon
3
Neurocrine Biosciences
NBIX
$13.8B
$7.94M 5.95% 84,240
BDSX icon
4
Biodesix
BDSX
$62.6M
$6.2M 4.65% 5,039,633
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.38B
$5.97M 4.48% 249,400
QDEL icon
6
QuidelOrtho
QDEL
$1.95B
$5.4M 4.05% 65,203 +3,897 +6% +$323K
ELUT icon
7
Elutia
ELUT
$96.7M
$3.91M 2.93% 1,655,184
IMGN
8
DELISTED
Immunogen Inc
IMGN
$3.59M 2.69% 190,000 +40,000 +27% +$755K
UTHR icon
9
United Therapeutics
UTHR
$13.8B
$3.31M 2.48% 15,000
OVV icon
10
Ovintiv
OVV
$10.8B
$3.21M 2.4% 84,200
HROW icon
11
Harrow
HROW
$1.44B
$2.86M 2.14% 150,000 -30,000 -17% -$571K
PHR icon
12
Phreesia
PHR
$1.88B
$2.56M 1.92% 82,700
MASI icon
13
Masimo
MASI
$7.59B
$2.51M 1.88% 15,280
FHTX icon
14
Foghorn Therapeutics
FHTX
$286M
$1.86M 1.4% 264,843
INBX
15
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.83M 1.37% 70,448
AXDX
16
DELISTED
Accelerate Diagnostics
AXDX
$1.82M 1.37% 2,252,388
ALKS icon
17
Alkermes
ALKS
$4.78B
$1.57M 1.17% 50,000
ATEC icon
18
Alphatec Holdings
ATEC
$2.35B
$1.44M 1.08% 80,000
ETRN
19
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.27M 0.95% 133,050
CORT icon
20
Corcept Therapeutics
CORT
$7.35B
$1.11M 0.83% 50,000
APLS icon
21
Apellis Pharmaceuticals
APLS
$3.48B
$1.09M 0.82% 12,000
SLNO icon
22
Soleno Therapeutics
SLNO
$3.6B
$1.05M 0.79% 245,127
PTGX icon
23
Protagonist Therapeutics
PTGX
$3.67B
$1.05M 0.79% 38,000
DCGO icon
24
DocGo
DCGO
$153M
$1.03M 0.77% 110,000
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$984K 0.74% 25,000